OSM CAR-T Therapy Shows Promise Against Osteosarcoma in Preclinical Studies
核心洞察
Researchers at Case Western Reserve University developed OSM CAR-T (搜索) therapy that successfully attacks osteosarcoma (搜索) tumors in mouse models by targeting Oncostatin M protein receptors.
The therapy showed anti-tumor effects against all osteosarcoma (搜索) patient samples tested and effectively killed metastatic tumor cells in mouse models.
Clinical trials are anticipated within two years, potentially offering the first major treatment advance for osteosarcoma (搜索) in 40 years.
Researchers at Case Western Reserve University and University Hospitals (搜索) have developed a novel CAR-T cell therapy that demonstrates promising preclinical results against osteosarcoma (搜索), the most common bone cancer (搜索) affecting children and young adults. The study, published in BMC Medicine, represents a potential breakthrough in treating a cancer that has seen little therapeutic advancement in four decades.
The engineered immune-cell treatment, called OSM CAR-T (搜索), successfully attacked osteosarcoma (搜索) tumors in mouse models by targeting receptors of Oncostatin M (OSM (搜索)), a protein that appears on the surface of osteosarcoma cells. This approach allows the engineered immune cells to identify multiple receptors on cancer cells simultaneously, addressing a key challenge in applying CAR-T therapy (搜索) to solid tumors.
Addressing an Unmet Medical Need
Osteosarcoma (搜索) primarily affects children, teenagers, and young adults during periods of rapid bone growth, with approximately 1,000 new cases diagnosed annually in the United States, according to The Osteosarcoma Institute (搜索). The disease's cause remains unknown but appears linked to DNA changes in bone-forming cells and, in rare cases, genetics.
"For the past 40 years, conventional therapies for osteosarcoma (搜索), which consist of chemotherapy (搜索) and surgery, have not changed much," said Reshmi Parameswaran, the study's lead researcher and associate professor in the Department of Medicine at Case Western Reserve School of Medicine. "Our new approach offers the possibility of a targeted treatment that harnesses the body's own immune system to fight the cancer—potentially offering better outcomes with fewer side effects than traditional chemotherapy."
Overcoming CAR-T Limitations in Solid Tumors
While CAR-T therapy (搜索) has revolutionized treatment for blood cancers like leukemia (搜索) and lymphoma (搜索), it has proven far less effective against solid tumors like osteosarcoma (搜索). The National Cancer Institute notes that cancer cells in solid tumors are more complex, displaying different markers on their surfaces, which makes it difficult for CAR-T cells to find and attack all cancer cells effectively.
The research team addressed this challenge by engineering CAR-T cells to target OSM (搜索) receptors, representing a novel approach that enables the immune cells to recognize multiple surface markers simultaneously.
Promising Preclinical Results
"The OSM CAR-T (搜索) cell therapy showed anti-tumor effects against all osteosarcoma (搜索) patient samples tested," Parameswaran reported. The therapy demonstrated particular promise in addressing metastatic disease (搜索), a serious complication that makes osteosarcoma patients non-responsive to most existing therapies.
"OSM CAR-T (搜索) cells were effective in killing tumor cells spread to other organs in mouse models, which brings hope to these patients," Parameswaran added. This finding is particularly significant given that metastatic osteosarcoma (搜索) represents one of the most challenging aspects of the disease to treat.
Path to Clinical Translation
The collaborative research environment at Case Western Reserve University and the institutional support from the university's Comprehensive Cancer Center and University Hospitals (搜索) provided the necessary infrastructure, expertise, and resources to develop this innovative cancer immunotherapy.
The research team anticipates that the treatment will be tested in clinical trials within two years. If successful in human studies, the therapy could offer a new treatment option for osteosarcoma (搜索) patients, potentially reducing the need for extensive surgery and providing hope for those with metastatic disease (搜索) who currently have limited therapeutic options.